Effects of tDCS in M1 and DLPFC on Pain Processing in Healthy Volunteers

October 28, 2020 updated by: Josue Fernandez Carnero, Universidad Rey Juan Carlos

Effects of Transcranial Direct Current Stimulation on Primary Cortex and Prefrontal Dorsolateral Cortex in Pain Processing on Healthy Volunteers: A Triple Blind Randomized Controlled Trial.

The purpose of this study is to evaluate the effects of a direct current applied transcranial over two cortical areas on healthy volunteers' pain processing.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcorcon, Madrid, Spain, 28922
        • Universidad Rey Juan Carlos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 18 and 40 years
  • Comprehension of the study tasks

Exclusion Criteria:

  • Presence of pain in the previous 6 months
  • Altered sensitivity in the tested regions
  • Intolerance to electrotherapy
  • Presence of pacemakers or any other implanted device
  • Ulcers or scars in the skin at the location of the electrodes
  • Treatment with direct current stimulation within one week
  • Pregnancy
  • Frequent headaches
  • Epilepsy
  • History of neuromuscular disease
  • Previous clinical history of cervical surgery
  • Injuries or surgery affecting the upper limb
  • diabetes mellitus
  • Cardiovascular diseases
  • Oncological diseases
  • Consumption of analgesic drugs 7 days before the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: M1 stimulation
A 20 minutes 1mA direct current stimulation over left M1.
Direct current application over the scalp to stimulate and change the excitability of the cortical areas underneath the electrodes (in this case left primary motor cortex and left dorsolateral prefrontal cortex).
Active Comparator: M1+DLPFC stimulation
A 20 minutes 1mA direct current stimulation over left M1 and 1mA direct current stimulation over left DLPFC.
Direct current application over the scalp to stimulate and change the excitability of the cortical areas underneath the electrodes (in this case left primary motor cortex and left dorsolateral prefrontal cortex).
Sham Comparator: Sham stimulation
A 20 minutes sham stimulation where the device only is working first 30s and last 30s of the intervention and have a 10 seconds fade out in intensity at each ramp.
Direct current application over the scalp to stimulate and change the excitability of the cortical areas underneath the electrodes (in this case left primary motor cortex and left dorsolateral prefrontal cortex).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conditioned Pain Modulation
Time Frame: Pre-intervention and immediately after treatment
Pain pressure threshold change after a painful ischemic stimulus
Pre-intervention and immediately after treatment
Pain pressure algometer temporal summation
Time Frame: Pre-intervention and immediately after treatment
Change in pain perceived between the first and tenth painful pressure stimulus
Pre-intervention and immediately after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain pressure threshold
Time Frame: Pre-intervention and immediately after treatment
Measurement of pressure applied until the perception of pain
Pre-intervention and immediately after treatment
Pain pressure tolerance
Time Frame: Pre-intervention and immediately after treatment
Measurement of maximal painful pressure tolerate using a pressure algometer
Pre-intervention and immediately after treatment
Neural mechanosensitivity
Time Frame: Pre-intervention and immediately after treatment
Measurement of range of motion achieved until the perception of tension
Pre-intervention and immediately after treatment
Cold hyperalgesia with a cold pack
Time Frame: Pre-intervention and immediately after treatment
Pain rated in a visual analogue scale after 10 seconds of a cold stimulus
Pre-intervention and immediately after treatment
Isometric grip strength
Time Frame: Pre-intervention and immediately after treatment
Maximal pressure achieved in a isometric gripping task
Pre-intervention and immediately after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Josue Fernandez Carnero, PhD, Rey Juan Carlos University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2020

Primary Completion (Actual)

July 25, 2020

Study Completion (Actual)

July 25, 2020

Study Registration Dates

First Submitted

June 9, 2020

First Submitted That Met QC Criteria

June 12, 2020

First Posted (Actual)

June 16, 2020

Study Record Updates

Last Update Posted (Actual)

October 30, 2020

Last Update Submitted That Met QC Criteria

October 28, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 30012020204820

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain Processing in Healthy Volunteers

Clinical Trials on Transcranial direct current stimulation

3
Subscribe